CA2069202C - The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery - Google Patents
The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery Download PDFInfo
- Publication number
- CA2069202C CA2069202C CA002069202A CA2069202A CA2069202C CA 2069202 C CA2069202 C CA 2069202C CA 002069202 A CA002069202 A CA 002069202A CA 2069202 A CA2069202 A CA 2069202A CA 2069202 C CA2069202 C CA 2069202C
- Authority
- CA
- Canada
- Prior art keywords
- propylxanthine
- methyl
- oxohexyl
- interruption
- blood circulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4116799 | 1991-05-23 | ||
DEP4116799.6 | 1991-05-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2069202A1 CA2069202A1 (en) | 1992-11-24 |
CA2069202C true CA2069202C (en) | 2003-12-09 |
Family
ID=6432229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002069202A Expired - Lifetime CA2069202C (en) | 1991-05-23 | 1992-05-22 | The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery |
Country Status (16)
Country | Link |
---|---|
US (1) | US5475002A (zh) |
EP (1) | EP0514789B1 (zh) |
JP (1) | JP3193767B2 (zh) |
KR (1) | KR100219011B1 (zh) |
AT (1) | ATE142498T1 (zh) |
AU (1) | AU651205B2 (zh) |
CA (1) | CA2069202C (zh) |
DE (1) | DE59207086D1 (zh) |
DK (1) | DK0514789T3 (zh) |
ES (1) | ES2093138T3 (zh) |
GR (1) | GR3021039T3 (zh) |
HU (1) | HU207798B (zh) |
IE (1) | IE75890B1 (zh) |
IL (1) | IL101953A (zh) |
TW (1) | TW207497B (zh) |
ZA (1) | ZA923747B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992021344A2 (en) * | 1991-05-24 | 1992-12-10 | Fred Hutchinson Cancer Research Center | Modulation of cellular response to external stimuli |
US5981536A (en) * | 1996-07-31 | 1999-11-09 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the modulation of apoptosis |
US5856330A (en) * | 1996-07-31 | 1999-01-05 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
US6413976B1 (en) | 1999-04-06 | 2002-07-02 | Trustees Of Dartmouth College | Compositions and method for decreasing neuropathic pain |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2330742C2 (de) * | 1973-06-16 | 1982-07-29 | Hoechst Ag, 6000 Frankfurt | 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
JPH062675B2 (ja) * | 1985-04-05 | 1994-01-12 | ヘキストジヤパン株式会社 | 記憶障害治療剤 |
-
1992
- 1992-05-15 EP EP92108250A patent/EP0514789B1/de not_active Expired - Lifetime
- 1992-05-15 DK DK92108250.9T patent/DK0514789T3/da active
- 1992-05-15 DE DE59207086T patent/DE59207086D1/de not_active Expired - Lifetime
- 1992-05-15 ES ES92108250T patent/ES2093138T3/es not_active Expired - Lifetime
- 1992-05-15 AT AT92108250T patent/ATE142498T1/de active
- 1992-05-21 HU HU9201695A patent/HU207798B/hu unknown
- 1992-05-21 KR KR1019920008617A patent/KR100219011B1/ko not_active IP Right Cessation
- 1992-05-21 IL IL10195392A patent/IL101953A/en not_active IP Right Cessation
- 1992-05-22 JP JP13068992A patent/JP3193767B2/ja not_active Expired - Lifetime
- 1992-05-22 ZA ZA923747A patent/ZA923747B/xx unknown
- 1992-05-22 CA CA002069202A patent/CA2069202C/en not_active Expired - Lifetime
- 1992-05-22 AU AU17063/92A patent/AU651205B2/en not_active Expired
- 1992-07-01 IE IE921658A patent/IE75890B1/en not_active IP Right Cessation
- 1992-08-28 TW TW081106779A patent/TW207497B/zh not_active IP Right Cessation
-
1993
- 1993-11-22 US US08/155,535 patent/US5475002A/en not_active Expired - Lifetime
-
1996
- 1996-09-13 GR GR960402398T patent/GR3021039T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5475002A (en) | 1995-12-12 |
AU1706392A (en) | 1992-11-26 |
ES2093138T3 (es) | 1996-12-16 |
ATE142498T1 (de) | 1996-09-15 |
HUT61469A (en) | 1993-01-28 |
IE921658A1 (en) | 1992-12-02 |
TW207497B (zh) | 1993-06-11 |
HU9201695D0 (en) | 1992-08-28 |
IE75890B1 (en) | 1997-09-24 |
KR100219011B1 (ko) | 1999-09-01 |
JP3193767B2 (ja) | 2001-07-30 |
IL101953A (en) | 1995-07-31 |
EP0514789B1 (de) | 1996-09-11 |
JPH05139976A (ja) | 1993-06-08 |
GR3021039T3 (en) | 1996-12-31 |
AU651205B2 (en) | 1994-07-14 |
EP0514789A1 (de) | 1992-11-25 |
DK0514789T3 (zh) | 1997-02-17 |
DE59207086D1 (de) | 1996-10-17 |
IL101953A0 (en) | 1992-12-30 |
CA2069202A1 (en) | 1992-11-24 |
HU207798B (en) | 1993-06-28 |
ZA923747B (en) | 1992-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5212176A (en) | R(+)-terazosin | |
US5449665A (en) | Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty | |
RU2272031C2 (ru) | Замещенные 2-анилино-бензимидазолы, их применение в качестве ингибиторов na+/h+-обмена, а также содержащее их лекарственное средство | |
PT1437131E (pt) | Utilização de ramipril para a prevenção de diabetes num doente sem insuficiência cardíaca congestiva pré-existente | |
CA2069202C (en) | The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery | |
EP1004316B1 (en) | Therapeutics for diabetic complications | |
JPH07188022A (ja) | 抗低酸素症薬および防御薬としてのフタロイルヒドラ ジド誘導体の使用 | |
CZ282140B6 (cs) | Deriváty xanthinu, způsob jejich výroby a farmaceutický prostředek tyto látky obsahující | |
NO161220B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 7-piperidin-1,2,3,5-tetrahydroimidazo-(2,1-b)-kinazolin-2-on. | |
CA2531406A1 (en) | Aporphine and oxoaporphine and the medical use thereof | |
HU226370B1 (en) | Carbohydrate derivatives with antithrombotic activity and pharmaceutical compositions contg. them | |
WO1999013874A1 (en) | Treating/preventing heart failure via inhibition of mast cell degranulation | |
CN101342238B (zh) | 一种治疗心脑血管疾病的药物组合物 | |
US20100168193A1 (en) | Therapeutic use of imidazole-5-carboxylic acid derivatives | |
US4868197A (en) | Reducing reperfusion injury with 1,3-dihydro-4-methyl-5-(4-methylthio)benzoyl)-2H-imidazol-2-thione | |
EP0308059B1 (en) | 1,2,3,4-tetrahydroisoquinoline antiarrhythmic agents | |
Raithel | Prevention of reocclusion after prosthetic bypass operations in the femoro-popliteal region: a comparative study of pentoxifylline versus acetylsalicylic acid | |
EP0115331B1 (en) | Medicament for cerebral apoplexy | |
JP3247763B2 (ja) | キサンチン誘導体からなる血液循環の中断による神経損傷の治療用医薬 | |
EP0872239B1 (en) | Use of olanzapine for the manufacture of a medicament for the treatment of cerebral focal ischemia | |
CN112469708B (zh) | 一类具有神经保护作用的化合物及其制备方法和用途 | |
JPH0615472B2 (ja) | アレルギー疾患治療剤 | |
LASSER et al. | Death following use of tetraethylammonium chloride | |
JPH05246850A (ja) | 脳循環の自己調節を安定化するためのキサンチン誘導体の使用 | |
CN104138599A (zh) | 一种药物组合物的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |